Former Neuralink co-founder and now-CEO of Science Corp., Max Hodak, is pushing far beyond the brain-computer interface work that defined his early career. Science Corp. has already acquired and refined a retinal-implant technology — dubbed Prima — which, in clinical trials, enabled about 80 percent of blind patients to read again letter by letter. But…